Fluidics for Preclinical Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

The Fluidics for Preclinical Market is Segmented by Product Type (Software and Accessories and Precision Syringe Pumps), Application, and Geography

Home Market Analysis Healthcare Research Biotechnology Research Bioservices Research Clinical Trial Services Research Fluidics for Preclinical Market

Fluidics for Preclinical Market Size

Image
Study Period 2018 - 2028
Base Year For Estimation 2021
CAGR 4.00 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Fluidics for Preclinical Market

*Disclaimer: Major Players sorted in no particular order
setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Fluidics for Preclinical Market Analysis

The fluidics for the preclinical market is expected to register a CAGR of 4% during the estimated period. Mounting demand for point-of-care testing, increasing focus on data precision and accuracy, faster testing results & improved portability through microfluidic chip miniaturization, and technological advancements are the major factors driving the market growth.

Globally, the growing incidence of various diseases and chronic conditions has increased the demand for advanced therapeutics. This has resulted in a surge in the number of cellular studies on chronic conditions and their cure, which has increased the use of technologies such as microfluidics. For instance, according to OECD, Health at a Glance, 2019 report, almost one-third of people aged 15 years and over has reported living with two or more chronic conditions, that include cancer, heart attack and stroke, chronic respiratory problems, and diabetes, on average across 27 OECD countries globally.

According to the Department of Economic and Social Affairs Population Division of United Nations, in 2017, the global population who are 60-year-old will double, and those who are 80 years will triple during the next thirty years. This increase in the number of chronic diseases will help ultimately increase the demand of microfluidic research on chronic diseases and is expected to increase the demand for such fluidic products and consequently drive the market during the forecast period.

Fluidics for Preclinical Market Trends

This section covers the major market trends shaping the Fluidics for Preclinical Market according to our research experts:

Software and Accessories Segment is Expected to the Fastest Growing Segment in The Forecast Period

The rising incidence of chronic disorders surgeries which accounts for rising point of care demand is the major reason driving the market growth. The increasing demand for high-throughput screening methodologies, low-volume sample analysis, demand for In Vitro Diagnostics (IVD), and the development of novel technologies advanced lab-on-a-chip technologies are also found to be the major factors boosting the market growth.

Major players in the market are also pursuing product launches based on novel technologies that are also driving the market growth. For instance, in July 2020, Fluidic Analytics, UK has launched the Fluidity One‑W Serum. The new instrument provides quantitative insights into the antibody response to COVID‑19 that cannot easily be obtained with traditional antibody tests. Also, Akura Flow - organ-on-a-chip manufactured by InSphero’s was showcased in the scientific journal SLAS Technology in 2019. Hence all these developments are going to propel market growth in the future.

Picturexx.png

North America Dominates the Fluidics for Preclinical Market

North America captures the market for the preclinical market and it is expected to do so even in the forecast period. Key factors attributing to the tremendous growth in this region are the rising aging population, presence of established vendors, and the increasing prevalence of chronic diseases in this region owing to the high obesity rate and unhealthy lifestyle.

In September 2019, Fluidigm Corporation, an American Company launched a novel microfluidics-based workflow, Advanta RNA-Seq NGS Library Prep Kit, designed for the preparation of RNA sequencing libraries. This strategy was aimed at expanding Juno Microfluidic System’s applications across high-throughput laboratories.

Favorable government policies and initiatives intended to gain customer attention by spending on healthcare infrastructure, improving reimbursement packages and cost-effectiveness of products and services offerings, streamlining research and developments to make innovative products are the major factors expected to project the growth of the market.

fluidics geo.png

Fluidics for Preclinical Industry Overview

The fluidics for the preclinical market is moderately competitive. To strengthen position in the market key players are adopting strategies such as mergers & acquisitions, agreements, product launches, and partnerships. For instance, in March 2019, Dolomite Microfluidics launched µEncapsulator Systems, it's novel microencapsulation system. These inorganic strategies to expand businesses, thus further giving rise to competition and pricing pressure among the players.

Fluidics for Preclinical Market Leaders

  1. Blacktrace Holdings Ltd.

  2. Fluigent SA

  3. Halma Plc

  4. Precigenome LLC

  5. PerkinElmer Inc.

*Disclaimer: Major Players sorted in no particular order

competitive 1.png
Need More Details on Market Players and Competitors?
Download PDF

Fluidics for Preclinical Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Preclinical Researches

      2. 4.2.2 Increasing Incidence of Chronic Disorders

    3. 4.3 Market Restraints

      1. 4.3.1 Strignent Regulatory Framework

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Software and Accessories

      2. 5.1.2 Precision Syringe Pumps

    2. 5.2 By Application

      1. 5.2.1 Life Science Research

      2. 5.2.2 Clinical Application

    3. 5.3 By Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 United Kingdom

        2. 5.3.2.2 Germany

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Rest of the World

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies Ltd

        1. 6.1.1.1 AMETEK Inc

        2. 6.1.1.2 Blacktrace Holdings Ltd.

        3. 6.1.1.3 Fluigent SA

        4. 6.1.1.4 Halma Plc

        5. 6.1.1.5 Harvard Bioscience Inc.

        6. 6.1.1.6 Hollister Incorporated

        7. 6.1.1.7 PerkinElmer Inc.

        8. 6.1.1.8 Precigenome LLC

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Fluidics for Preclinical Industry Segmentation

As per the scope of the report, fluidics for preclinical is a combination of science and technology, which is used in studying the behavior of fluids through micro-channels. It manipulates and controls fluids in a network of channels with dimensions from tens to hundreds of micrometers.

Need A Different Region Or Segment?
Customize Now

Fluidics for Preclinical Market Research FAQs

The Fluidics for Preclinical Market is projected to register a CAGR of 4% during the forecast period (2023-2028).

Blacktrace Holdings Ltd., Fluigent SA, Halma Plc, Precigenome LLC and PerkinElmer Inc. are the major companies operating in the Fluidics for Preclinical Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2023-2028).

In 2023, the North America accounts for the largest market share in the Fluidics for Preclinical Market.

Fluidics for Preclinical Industry Report

Statistics for the 2023 Fluidics for Preclinical market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Fluidics for Preclinical analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Fluidics for Preclinical Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!